The total number of records retrieved from this search are 4. Click on ID to see further detail.

ID	Virus name	Virus strain	Virus genome type	Virus family	Virus genome modification	Virus alone	Virus in combination with drug/radiation	Immune gene insertion in viral genome	Source of cell line	Origin of cell line	Cell line	Concentration of cell line	In-vitro toxicity	Assay	In-vitro virus concentration	In-vitro result	Model organism	In-vivo virus concentration	In-vivo toxicity	In-vivo result	Mode of delivery	Pathway induced	Immunogenic effect	Clinical trial	PMID
OV_3138	Herpes simplex virus	HSV-HSV-GR	DNA	Herpesviridae	Deletion of gamma 34.5 gene and insertion of GR and mcherry	Yes	No	No	National cell bak of Iran	Murine breast cancer cell line	4T1	NA	NA	Photomicrography and flow cytometry	1 MOI	27.9% cancer cell killing	No	No	NA	No response	NA	NA	NA	NA	30936930
OV_4282	Alphavirus	M1	RNA	Togaviridae	None	Yes	No	No	ATCC	Human breast carcinoma	4T1	4000 cells per well	NA	MTT assay	10 pfu	26.27 % cell viability after 72 hours	No	No	NA	No response	NA	Activation of cAMP signalling leads to induced expression of antiviral factors, severe ER stress and cell apoptosis	NA	NA	26373347
OV_5369	Maraba virus	MG1	RNA	Rhabdoviridae	None	Yes	No	No	ATCC	Murine triple negative breast cancer cell line	4T1	NA	NA	Coomassie brilinat blue staining	4 micromolar	70% cell killing after 48 hours	No	No	NA	No response	NA	Induction of apoptosis	NA	In clinical trial for various cancer cell line	27503504
OV_5372	Maraba virus	MG1	RNA	Rhabdoviridae	None	No	Virus in combination with 2 micromolar palcitaxel for 48 hours	No	ATCC	Murine triple negative breast cancer cell line	4T1	NA	NA	Coomassie brilinat blue staining	4 micromolar	10% cell viability after 48 hours	No	No	NA	No response	NA	Induction of apoptosis	Impaired IFN beta production by combination	In clinical trial for various cancer cell line	27503504